Febrile neutropenia primary prophylaxis with granulocyte-colony stimulating factors (G-CSF) in breast cancer

被引：0
|
作者：
Younis, T.
Rayson, D.
Skedgel, C.
机构：
[1] Dalhousie Univ, Halifax, NS, Canada
[2] Queen Elizabeth 2 Hlth Sci Ctr, ACCRU, Halifax, NS, Canada
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P6-07-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-07-07
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prophylaxis of Febrile Neutropenia with granulocyte-colony stimulating factor
    Takamatsu, Yasushi
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 59 - 59
  • [2] Neonatal sepsis with neutropenia: granulocyte-colony stimulating factor (G-CSF)
    Silvinato, Antonio
    Bernardo, Wanderley Marques
    Floriano, Idevaldo
    Bastos Soledade, Gabriel Nogueira
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (01): : 3 - 10
  • [3] Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
    Chris Skedgel
    Daniel Rayson
    Tallal Younis
    [J]. Supportive Care in Cancer, 2016, 24 : 387 - 394
  • [4] Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors
    Laali, Elahe
    Fazli, Jinous
    Sadighi, Sanambar
    Mohammadi, Mehdi
    Gholami, Kheirollah
    Jahangard-Rafsanjani, Zahra
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 428 - 433
  • [5] Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
    Skedgel, Chris
    Rayson, Daniel
    Younis, Tallal
    [J]. SUPPORTIVE CARE IN CANCER, 2016, 24 (01) : 387 - 394
  • [6] COST-UTILITY OF GRANULOCYTE-COLONY STIMULATING FACTORS FOR PRIMARY PROPHYLAXIS OF CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA IN BREAST CANCER PATIENTS IN BELGIUM
    Somers, L.
    Malfait, M.
    Danel, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A427 - A427
  • [7] USE OF A GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) AS PRIMARY OR SECONDARY PROPHYLAXIS FOR CHEMO-INDUCED FEBRILE NEUTROPENIA (FN): RESULTS OF THE OBSTIM FRENCH SURVEY
    Lotz, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 502 - 502
  • [8] Granulocyte-colony stimulating factor (G-CSF) administration for chemotherapy-induced neutropenia
    Yalcin, S
    Guler, N
    Kansu, E
    Ertenli, I
    Gullu, I
    Kars, A
    Akpek, G
    Barista, I
    Tekuzman, G
    Baltali, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 591 - 591
  • [9] Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review
    Lapidari, Pietro
    Vaz-Luis, Ines
    Di Meglio, Antonio
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [10] An audit into granulocyte-colony stimulating factor (G-CSF) primary prophylaxis for early breast cancer chemotherapy at the North Middlesex University Hospital (NMUH)
    Smith, T. C.
    Jenkinson, S.
    Raja, F.
    [J]. CLINICAL ONCOLOGY, 2016, 28 : S12 - S13
12345